emc receives over 40 million visits per year, with 72% of HCPs stating this resource as their first-choice source of medicines information. For a deeper look at the survey findings and its ...

In oncology care, clinical success is defined primarily by time: months or years of survival. Yet for patients living with ...

What began as a convenience play has evolved into something more consequential: a shift in where trust is built; how ...

Looking across late-stage pharma R&D, three dominant themes emerge for 2026. These reflect a maturing AI landscape, ...

Marketing-centric engagement, designed for lower-complexity markets where scale and awareness are priorities. This model ...

A major shift in approach is needed if patient-reported adverse events are to enable clearer safety insights and better ...

Whether they are navigating a tough media grilling as a crisis unfolds or translating a complex research breakthrough for a ...

Ahmed Moussa has been appointed as the new Sanofi Country Lead for the UK & Ireland, taking over from Rippon Ubhi. In his new ...

Despite all their talk of more strategic exploitation of data over the last ten to 15 years, the life sciences remain ...

Gene therapies delivered major breakthroughs, including treatments that halve cholesterol levels in patients with inherited cardiovascular risk, advances for people living with thalassemia and highly ...

ALK has announced that its EURneffy 1mg nasal adrenaline spray has received a positive opinion from the Committee for ...

ENA Respiratory has started dosing participants in its phase 2 community study of INNA‑051, a dry‑powder nasal spray designed to strengthen the body’s natural antiviral defences and reduce the impact ...